🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
This is a phase II, observer-blind, multiple-centre, randomized, placebo-co...
Status
Terminated
Location
Changhua Christian Hospital
Start Date
2021-01-30
Trial ID
NCT04773067
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
Phase II study to evaluate safety and efficacy of DCP-001 in patients with ...
Status
Unknown
Location
Helsinki University Hospital
Start Date
2018-10-15
Trial ID
NCT03697707
Treatments Being Tested
Combination approaches will almost certainly be required to generate durabl...
Status
Completed
Location
Zuckerberg San Francisco General Hospital, University of California San Francisco
Start Date
2020-08-01
Trial ID
NCT04357821
Treatments Being Tested
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
The purpose of this study is to evaluate the safety and immune response of ...
Status
Completed
Location
University of Rochester
Start Date
2000-11
Trial ID
NCT00133549
Treatments Being Tested
The purpose of this study is to complete the total safety database size for...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-19
Trial ID
NCT03954743